AR069142A1 - Uso de lineas celulares de huron para el crecimiento de ortomixivirus, metodos para la atenuacion y crecimiento de ortomixivirus - Google Patents

Uso de lineas celulares de huron para el crecimiento de ortomixivirus, metodos para la atenuacion y crecimiento de ortomixivirus

Info

Publication number
AR069142A1
AR069142A1 ARP080104778A ARP080104778A AR069142A1 AR 069142 A1 AR069142 A1 AR 069142A1 AR P080104778 A ARP080104778 A AR P080104778A AR P080104778 A ARP080104778 A AR P080104778A AR 069142 A1 AR069142 A1 AR 069142A1
Authority
AR
Argentina
Prior art keywords
growth
ortomixivirus
methods
cell lines
huron
Prior art date
Application number
ARP080104778A
Other languages
English (en)
Inventor
Carla Christina Schrier
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of AR069142A1 publication Critical patent/AR069142A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16111Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16161Methods of inactivation or attenuation
    • C12N2710/16164Methods of inactivation or attenuation by serial passage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16051Methods of production or purification of viral material
    • C12N2760/16052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151Methods of production or purification of viral material
    • C12N2760/16152Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Uso de líneas celulares de huron para el crecimiento de un virus de la familia Ortomixovirus, con los métodos para la atenuacion del Ortomixovirus y con los métodos para el crecimiento de la familia Ortomixoviridae.
ARP080104778A 2007-11-02 2008-10-31 Uso de lineas celulares de huron para el crecimiento de ortomixivirus, metodos para la atenuacion y crecimiento de ortomixivirus AR069142A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98478407P 2007-11-02 2007-11-02
EP07119867 2007-11-02

Publications (1)

Publication Number Publication Date
AR069142A1 true AR069142A1 (es) 2009-12-30

Family

ID=39722699

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080104778A AR069142A1 (es) 2007-11-02 2008-10-31 Uso de lineas celulares de huron para el crecimiento de ortomixivirus, metodos para la atenuacion y crecimiento de ortomixivirus

Country Status (5)

Country Link
AR (1) AR069142A1 (es)
PE (1) PE20091726A1 (es)
TW (1) TW200936758A (es)
UY (1) UY31449A1 (es)
WO (1) WO2009056628A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011006880A1 (en) * 2009-07-14 2011-01-20 Intervet International B.V. Lawsonia intracellularis propagation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
US6743631B1 (en) * 1998-03-17 2004-06-01 North Shore University Hospital Research Corporation Use of human serum resistant vector particles and cell lines for human gene therapy

Also Published As

Publication number Publication date
TW200936758A (en) 2009-09-01
PE20091726A1 (es) 2009-11-13
WO2009056628A1 (en) 2009-05-07
UY31449A1 (es) 2009-05-29

Similar Documents

Publication Publication Date Title
UY34585A (es) Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
UY34200A (es) 3-(fluorovinil)pirazoles y su uso
CL2012000752A1 (es) Compuestos derivados de fenilpiri(mi)dinilpirazoles para el control de microorganismos no deseados en la proteccion de plantas y compuestos intermediarios.
CR11232A (es) Compuestos de tiazolopirina modulares de sirtuina
UY4151Q (es) Vincha con auriculares
UY34419A (es) Profármaco de adrenomedulina basado en polietilenglicol y el uso del mismo
UY34515A (es) Triazolopiridinas sustituidas
UY34167A (es) Pirrolotriazinas sustituidas con hidroximetilarilo y sus usos
UY34797A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
UY33856A (es) ?gen y variaciones asociadas con el fenotipo bm1, marcadores moleculares y su uso?.
BR112012033231A2 (pt) peças revestidas e seu uso
UY34590A (es) Fenilimidazopirazoles sustituidos y su uso
UY34360A (es) ?compuestos de tipo bisamida con actividad insecticida, procesos e intermediarios?
BR112015013051A2 (pt) gerenciamento de alimentação de dispositivos de comunicação
AR084121A1 (es) Material celulosico
AR069142A1 (es) Uso de lineas celulares de huron para el crecimiento de ortomixivirus, metodos para la atenuacion y crecimiento de ortomixivirus
EA201300514A1 (ru) Разлагаемые волокна
PA8852001A1 (es) Derivados de lisina y ornitina marcados con radioisótopos, su uso y procesos para su preparación
UY4237Q (es) Taburete
CL2012002063A1 (es) Proceso para hacer biodegradable un material polimerico sintetico, que comprende la adicion al material sintetico de una o mas levaduras; equipo para la implementacion de dicho proceso; y uso de levaduras.
HN2009003469A (es) Biscocho lleno
UY33210A (es) DERIVADOS DE PIRAZOLO-[5, 1b]-OXAZOL COMO ANTAGONISTAS DE LOS RECEPTORES DE CRF-1
AR081772A1 (es) Tratamiento de la artritis reumatoide con masitinib
CL2008003260A1 (es) Uso de una linea celular de huron para el crecimiento de un virus de la familia ortomixoviridae.
RU2009136584A (ru) Растительное антгельминтное средство

Legal Events

Date Code Title Description
FB Suspension of granting procedure